I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease
- 30 January 1997
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 30 (1) , 31-36
- https://doi.org/10.1016/s0197-0186(96)00035-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- An allelic association study of monoamine oxidase B in parkinson's diseaseAnnals of Neurology, 1995
- Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissuesNeuroscience Letters, 1994
- Hereditary variations in monoamine oxidase as a risk factor for Parkinson's diseaseMovement Disorders, 1994
- Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortexNeurochemistry International, 1993
- Relationship Between Platelet Monoamine Oxidase B Activity and Alleles at the MAOB LocusJournal of Neurochemistry, 1992
- Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological functionBritish Journal of Pharmacology, 1992
- Autoradiographic distribution of α2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscineBrain Research, 1991
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- A review of the pharmacology of selegilineActa Neurologica Scandinavica, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976